Use of Chemotherapy and Androgen Signaling-targeted Inhibitors in Patients with Metastatic Prostate Cancer

被引：4
|
作者：
de Wit, Ronald [1 ]
Tombal, Bertrand [2 ]
Freedland, Stephen [3 ,4 ]
机构：
[1] Erasmus Univ, Med Ctr, Med Oncol, Rotterdam, Netherlands
[2] Catholic Univ Louvain, Inst Rech Clin, Louvain, Belgium
[3] Cedars Sinai Med Ctr, Div Urol, Los Angeles, CA 90048 USA
[4] Durham VA Med Ctr, Sect Urol, Durham, NC USA
来源：
EUROPEAN UROLOGY | 2021年 / 79卷 / 02期
关键词：
INCREASED SURVIVAL; ENZALUTAMIDE; ABIRATERONE;
D O I：
10.1016/j.eururo.2020.10.016
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：170 / 172
页数：3
相关论文
共 50 条
  • [1] Use of androgen receptor signaling-targeted therapies in chemotherapy-naive metastatic castration-resistant prostate cancer: a call for patient-centered studies
    Kim, Won
    Ryan, Charles J.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (01) : 5 - 7
  • [2] Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer
    Csizmarik, Anita
    Hadaschik, Boris
    Kramer, Gero
    Nyirady, Peter
    Szarvas, Tibor
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 728.e13 - 728.e24
  • [3] Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration-resistant prostate cancer patients
    Tanegashima, Tokiyoshi
    Shiota, Masaki
    Tsukahara, Shigehiro
    Mutaguch, Jun
    Goto, Shunsuke
    Kobayashi, Satoshi
    Matsumoto, Takashi
    Eto, Masatoshi
    PROSTATE, 2024, 84 (14) : 1329 - 1335
  • [4] Quality of life for androgen receptor targeted agents in patients with metastatic castration resistant prostate cancer
    Kuzma, Monika
    Nekvindova, Lucie
    Kliment, Jan
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (09): : 572 - 579
  • [5] Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Luber, Brandon
    Wang, Hao
    Chen, Yan
    Nakazawa, Mary
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    JAMA ONCOLOGY, 2015, 1 (05) : 582 - 591
  • [6] Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer
    Li, Yingming
    Yang, Rendong
    Henzler, Christine M.
    Ho, Yeung
    Passow, Courtney
    Auch, Benjamin
    Carreira, Suzanne
    Rodrigues, Daniel Nava
    Bertan, Claudia
    Tae Hyun Hwang
    Quigley, David A.
    Dang, Ha X.
    Morrissey, Colm
    Fraser, Michael
    Plymate, Stephen R.
    Maher, Christopher A.
    Feng, Felix Y.
    de Bono, Johann S.
    Dehm, Scott M.
    CLINICAL CANCER RESEARCH, 2020, 26 (08) : 1965 - 1976
  • [7] Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgen-signaling-targeted inhibitor resistance
    Zhang, Peng-Fei
    Xie, Dan
    Li, Qiu
    BMC CANCER, 2021, 21 (01)
  • [8] Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression
    Li, Haolong
    Xie, Ning
    Gleave, Martin E.
    Dong, Xuesen
    ONCOTARGET, 2015, 6 (24) : 20474 - 20484
  • [9] Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors
    Zhong, Ying Yan
    Anton, Angelyn
    Xie, Owen
    Tan, Natalie
    O'Haire, Sophie
    Maleki, Sam
    Inderjeeth, Andrisha-Jade
    Parente, Phillip
    Spain, Lavinia
    Gibbs, Peter
    Tran, Ben
    JCO ONCOLOGY PRACTICE, 2024, 20 (09) : 1231 - 1242
  • [10] Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy
    Conteduca, Vincenza
    Caffo, Orazio
    Scarpi, Emanuela
    Sepe, Pierangela
    Galli, Luca
    Fratino, Lucia
    Maines, Francesca
    Chiuri, Vincenzo Emanuele
    Santoni, Matteo
    Zanardi, Elisa
    Massari, Francesco
    Toma, Ilaria
    Lolli, Cristian
    Schepisi, Giuseppe
    Sbrana, Andrea
    Kinspergher, Stefania
    Cursano, Maria Concetta
    Casadei, Chiara
    Modonesi, Caterina
    Santini, Daniele
    Procopio, Giuseppe
    De Giorgi, Ugo
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1
12345